Angiotensin converting enzyme (ACE) inhibitor (BF = 0.4286): potential role in blood pressure regulation and cardiovascular protection; dipeptidyl peptidase (DPP)-IV inhibitor (BF = 0.6429): possible application in diabetes management by enhancing insulin regulation. Here, INS is linked to diabetes mellitus.